| MAINZ BIOMED N.V. EO 1 |
| Niederlande |
| Gesundheit |
| NL0015000LC2 / A3C6XX |
| 4TO (Frankfurt) / MYNZ (NASDAQ) |
| FRA:4TO, ETR:4TO, 4TO:GR, NASDAQ:MYNZ |
| - |
| https://mainzbiomed.com/ |
|
Mainz Biomed N.V. is a biotechnology company primarily engaged in the development and commercialization of innovative diagnostic solutions. Headquartered in Mainz, Germany, this dynamic firm is dedicated to the advancement of early cancer detection t..
>Volltext.. |
| 4.97 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| MAINZ BIOMED |
| 04.04.26 |
|